हमारा समूह 1000 से अधिक वैज्ञानिक सोसायटी के सहयोग से हर साल संयुक्त राज्य अमेरिका, यूरोप और एशिया में 3000+ वैश्विक सम्मेलन श्रृंखला कार्यक्रम आयोजित करता है और 700+ ओपन एक्सेस जर्नल प्रकाशित करता है जिसमें 50000 से अधिक प्रतिष्ठित व्यक्तित्व, प्रतिष्ठित वैज्ञानिक संपादकीय बोर्ड के सदस्यों के रूप में शामिल होते हैं।
ओपन एक्सेस जर्नल्स को अधिक पाठक और उद्धरण मिल रहे हैं
700 जर्नल और 15,000,000 पाठक प्रत्येक जर्नल को 25,000+ पाठक मिल रहे हैं
Saurabh Gupta, Basavan Duraiswamy, Satish Kumar Muthureddy Nataraj, Rama Satyanarayana Raju K, Babu UV, Sharath Kumar LM, Omji Porwal and Renu Gupta
Yucca gloriosa (Agavaceae) is used in Indian traditional medicine as an antiallergic drug. The ethanol extract was prepared with aerial parts of Yucca gloriosa (YGE). Gloriosaol isomeric mixtures (GLM) are isolated from the extract, structurally confirmed FIA-MS/MS. Both YGE and GLM are evaluated against ovalbumin-induced airway hyperresponsiveness (AHR) in Balb/C mice. The test drugs (GLM or YGE or Dexamethasone) are administered p.o. prior to challenge with aerosolized 2.5% w/v ovalbumin. Total and differential leucocytes count, Nitrite (NO2), Nitrate (NO3), Tumor necrosis factor- α (TNF-α), Interlukin-6 (IL-6), and Interlukin-13 (IL-13) are estimated in bronchoalveolar lavage fluid (BALF). Similarly, Myeloperoxidase (MPO) and Malonaldehyde (MDA) are estimated in lungs. The results reveal a significant increase in total and differential leucocytes counts, NO2, NO3, TNF-α, IL-6, and IL-13 in ovalbumin induced AHR. However, these parameters are significantly decreased in YGE and GLM treated mice at test doses (YGE 100 & 200 mg/kg and GLM 30 mg/kg). Similar observations are recorded for Myeloperoxidase (MPO) and Malonaldehyde (MDA) in lungs. Pro inflammatory mediators are (TNF-α, IL-6, and IL-13) known that responsible for AHR. Histopathology reveled justify the effectiveness. The present investigations suggest both YGE and GLM are interesting molecules for the further research the treatment of asthma, with an approach through pro-inflammatory inhibitory pathway.